Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Acceleron Pharma Inc. (XLRN)

« Back to company index

XLRN Chatter Timeline

Stock Ticker for XLRN

Most Active Tweeters for XLRN

No tweets found

Recent Tweets for XLRN

dailypoliticaln @dailypoliticaln
$3.49 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/BIK4j0SLZW
August 22nd 2018, 12:08am
WatchlistN @WatchlistN
Zacks: Brokerages Anticipate Acceleron Pharma Inc $XLRN Will Announce Earnings of -$0.67 Per Share https://t.co/XvUVVFs85R
August 22nd 2018, 12:08am
MareaInformativ @MareaInformativ
-$0.67 Earnings Per Share Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/sTspyLrG2w
August 22nd 2018, 12:08am
TickerReport @TickerReport
$3.49 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/C9nSMLx04i
August 22nd 2018, 12:08am
MareaInformativ @MareaInformativ
Acceleron Pharma Inc $XLRN Holdings Cut by Alps Advisors Inc. https://t.co/dOKGyuuoiU
August 22nd 2018, 12:08am
IlliniJJ @IlliniJJ
$XLRN sold 50% of position at $48.89, want to get back in at a lower cost in the next 30 days.
August 21st 2018, 4:08pm
Biorunner1 @Biorunner1
$XLRN resistance @ $49.15+_ and then it runs
August 21st 2018, 2:08pm
keiner15780853 @keiner15780853
Binance reopen limited user registration Register link and BONUS ? https://t.co/8ML537TLGp ? 08/20 10:01 $XLRN… https://t.co/HjQTuwxBvm
August 20th 2018, 10:08pm
AmericanBanking @AmericanBanking
Head to Head Analysis: Audentes Therapeutics $BOLD & Acceleron Pharma $XLRN https://t.co/XECZJNYKKg #stocks
August 20th 2018, 12:08pm
MareaInformativ @MareaInformativ
Head to Head Analysis: Audentes Therapeutics $BOLD & Acceleron Pharma $XLRN https://t.co/9pQTJYdyI4
August 20th 2018, 12:08pm
TranscriptDaily @TranscriptDaily
Head to Head Analysis: Audentes Therapeutics $BOLD & Acceleron Pharma $XLRN https://t.co/BUiRCuyWKt
August 20th 2018, 12:08pm
Biotech2050 @Biotech2050
@tgtxdough $CELG & $XLRN might be looking at these #CKD #anemia statistics to decide on #sotatercept Keep us poste… https://t.co/4KlZWM9gjq
August 20th 2018, 12:08am
EnterpriseLeade @EnterpriseLeade
Acceleron Pharma Inc $XLRN Receives $51.50 Average Target Price from Analysts https://t.co/zoKHafDuOp
August 19th 2018, 11:08am
SwingTradeBot @SwingTradeBot
Recent $XLRN technical alerts: NR7 plus 4 more alerts... https://t.co/9CITuDOmfh
August 19th 2018, 9:08am
1MinuteStock @1MinuteStock
Recommendation #HOLD for $XLRN with UB rating - 2.25 out of 5. https://t.co/V323QXjJDi
August 19th 2018, 8:08am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $XLRN is $-0.64 it's -1.32% of the current price https://t.co/wB8VJQrjbz
August 19th 2018, 8:08am
bbnsnews @bbnsnews
-$0.67 Earnings Per Share Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/nzSYRMpUJg
August 19th 2018, 8:08am
j_jccnidan @j_jccnidan
$XLRN FYI you can see these in Yahoo Finance
August 19th 2018, 6:08am
j_jccnidan @j_jccnidan
$XLRN What’s even more interesting is that a trader either sold his December Puts or converted them to Calls...Hmmm Fireworks coming........
August 19th 2018, 6:08am
MarketChmln @MarketChmln
$XLRN option volume was 6X normal on Friday with 3,178 contracts. Call volume was 89% and put volume was 11%. https://t.co/ykkzoFtmpS
August 18th 2018, 8:08pm
ConsumerFeed @ConsumerFeed
Analysts Anticipate Acceleron Pharma Inc $XLRN Will Post Quarterly Sales of $3.49 Million https://t.co/G026ZvCpd5
August 18th 2018, 4:08am
AmericanBanking @AmericanBanking
Acceleron Pharma Inc $XLRN Expected to Announce Quarterly Sales of $3.49 Million https://t.co/1j87MNh5dH #stocks
August 18th 2018, 4:08am
registrarjourn @registrarjourn
Acceleron Pharma $XLRN Receives Media Impact Rating of 0.05 https://t.co/6PntW4tzXB
August 17th 2018, 5:08am
EnterpriseLeade @EnterpriseLeade
Acceleron Pharma $XLRN Receives Media Impact Rating of 0.05 https://t.co/liSCjPjDah
August 17th 2018, 5:08am
ThisLincolnian @ThisLincolnian
Acceleron Pharma Inc $XLRN Given Consensus Recommendation of “Buy” by Brokerages https://t.co/ySRaifRP63
August 17th 2018, 12:08am
registrarjourn @registrarjourn
Acceleron Pharma $XLRN – Research Analysts’ Weekly Ratings Updates https://t.co/yThOAtdact
August 16th 2018, 9:08am
WeekHerald @WeekHerald
-$0.67 EPS Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/pWoPenYiQd
August 16th 2018, 4:08am
OlympiaReport @OlympiaReport
Acceleron Pharma Inc $XLRN Expected to Announce Earnings of -$0.67 Per Share https://t.co/4BE0hi1cM3
August 16th 2018, 4:08am
AmericanBanking @AmericanBanking
Acceleron Pharma Inc $XLRN Expected to Announce Earnings of -$0.67 Per Share https://t.co/z8i5fZydqS #stocks
August 16th 2018, 4:08am
MareaInformativ @MareaInformativ
Brokerages Anticipate Acceleron Pharma Inc $XLRN Will Announce Quarterly Sales of $3.41 Million https://t.co/3goPYpIwRf
August 16th 2018, 4:08am
j_jccnidan @j_jccnidan
$XLRN Interesting How the Volume picked up at the close and the bid is. Ow higher than the close Hmmmm
August 15th 2018, 5:08pm
TickerReport @TickerReport
Acceleron Pharma $XLRN vs. Crispr Therapeutics $CRSP Head to Head Analysis https://t.co/D5EAx7MnbJ
August 15th 2018, 5:08pm
The_CasualSmart @The_CasualSmart
Acceleron Pharma $XLRN Shareholder Sectoral Asset Management Decreased Position; Muhlenkamp & Co Raised Position in… https://t.co/3GnUlGLk6U
August 15th 2018, 12:08pm
usindexlive @usindexlive
Acceleron Pharma $XLRN Shareholder Great Point Partners Boosted Its Stake; Holder Central Securities Has Lifted Gen… https://t.co/XpUoiFTnSY
August 15th 2018, 8:08am
MareaInformativ @MareaInformativ
Acceleron Pharma Inc $XLRN Position Lessened by Birchview Capital LP https://t.co/YTXjS2wuNN
August 14th 2018, 9:08pm
OlympiaReport @OlympiaReport
Acceleron Pharma Inc $XLRN Receives Consensus Rating of “Buy” from Analysts https://t.co/EaVvbtRr6B
August 14th 2018, 9:08pm
registrarjourn @registrarjourn
Acceleron Pharma $XLRN Receiving Somewhat Positive News Coverage, Report Finds https://t.co/qOlMX9UNPD
August 14th 2018, 2:08pm
EnterpriseLeade @EnterpriseLeade
Acceleron Pharma $XLRN Receiving Somewhat Positive News Coverage, Report Finds https://t.co/S0wA2c4stn
August 14th 2018, 2:08pm
j_jccnidan @j_jccnidan
$XLRN People don’t understand that software does not tell them about the company. Most people are to lazy to listen to CC
August 14th 2018, 8:08am
RuggeroRespigo @RuggeroRespigo
Ruggero Respigo : TD SELL $XLRN at 47.62, Supp 41.98 Resis 47.62 R13 HiLo 86% T1Y 57 buy 2.2 fwdPE -24.4 DIV N/A… https://t.co/wFYDpVXKH5
August 14th 2018, 3:08am
a3igner @a3igner
TradeFlags : TD SELL $XLRN at 47.62, Supp 41.98 Resis 47.62 R13 HiLo 86% T1Y 57 buy 2.2 fwdPE -24.4 DIV N/A… https://t.co/X6wWUgj0pg
August 14th 2018, 2:08am
TradeFlags @TradeFlags
TD SELL $XLRN at 47.62, Supp 41.98 Resis 47.62 R13 HiLo 86% T1Y 57 buy 2.2 fwdPE -24.4 DIV N/A #Acceleron #stocks… https://t.co/T4ML4kFgz5
August 14th 2018, 2:08am
j_jccnidan @j_jccnidan
$XLRN Buy on any weakness
August 13th 2018, 6:08pm
WatchlistN @WatchlistN
Head to Head Comparison: Crispr Therapeutics $CRSP & Acceleron Pharma $XLRN https://t.co/1gYo442XhD
August 13th 2018, 10:08am
j_jccnidan @j_jccnidan
$XLRN Inverted H&S to retest highs https://t.co/ifkg99YDK6
August 13th 2018, 8:08am
The_CasualSmart @The_CasualSmart
Sectoral Asset Management Cut Acceleron Pharma $XLRN Position by $19.04 Million as Market Value Declined; Blackston… https://t.co/LhcOZiBwzG
August 13th 2018, 6:08am
ZolmaxNews @ZolmaxNews
Acceleron Pharma $XLRN Rating Increased to Hold at BidaskClub https://t.co/CzIiguxNWQ
August 13th 2018, 2:08am
bibeypost_stock @bibeypost_stock
Artal Group Sa Decreased Acceleron Pharma Inc $XLRN Stake By $36.00 Million - https://t.co/d3ucj0w6lj
August 12th 2018, 8:08pm
reurope_stock @reurope_stock
Artal Group Sa Decreased Acceleron Pharma Inc $XLRN Stake By $36.00 Million https://t.co/tmji8fVNis
August 12th 2018, 8:08pm
The_CasualSmart @The_CasualSmart
Artal Group Sa Decreased Acceleron Pharma Inc $XLRN Stake By $36.00 Million https://t.co/xeEgzYyDE7
August 12th 2018, 8:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.